Safety Score
97/100
Excellent
Based on recall frequency and severity over the past 3 years, with older recalls weighted less.
Severity Breakdown
Class I — Serious
0Class II — Moderate
0Class III — Low Risk
0Unclassified
1Categories
MEDICATION
Recall Timeline
FDAAug 5, 2026
Fresenius Kabi Issues Voluntary Nationwide Recall of One Lot of Morphine Sulfate Injection, USP in a Simplist® Prefilled Syringe Due to Labeling Mix-up
FOR IMMEDIATE RELEASE – 8/4/2026 – LAKE ZURICH, Ill.— Fresenius Kabi, an operating company of the Fresenius Group, is voluntarily recalling one lot of Morphine Sulfate Injection USP, Simplist® 2 mg/1 mL due to a label mix-up. The MicroVault labeled as Morphine 2 mg/1 mL, may contain a Prefilled Syri
Track Fresenius Kabi Issues Voluntary Nationwide recalls automatically
Get instant alerts when Fresenius Kabi Issues Voluntary Nationwide issues a new recall.
Start Free Trial